Sundar PichaiSundar Pichai earned $164M in 2023

Mark Thierer served as the Interim CEO of DENTSPLY SIRONA from September 2017 until February 2018. Before this role, he was the CEO of OptumRx, a prominent pharmacy care services company. Thierer holds significant experience in the healthcare sector, especially...

Quick Links
D

Mark Thierer

Ex-CEO of DENTSPLY SIRONA

Sector of Economy

Healthcare

CEO of DENTSPLY SIRONA for

0 years 4 months (Sep 2017 - Feb 2018)

Previous Experience

Chief Executive Officer of OptumRx and Catamaran Corporation.

Holdings

See how much did Mark Thierer make over time.

Mark Thierer had a notable track record in insider trading from 2019 to 2024, where his holdings fluctuated significantly. In September 2019, his stake was valued at around $6.79 million, growing steadily every month. By May 2021, this number peaked...

Insider Trading

See recent insider trades of Mark Thierer.

XRAY

56.184 shares

XRAY

Jan 12, 2018

Received

XRAY

$5.08M

XRAY at $66.04/share

Nov 13, 2017

Purchase

XRAY

61.749 shares

XRAY

Oct 13, 2017

Received

XRAY

42,208 shares

XRAY

Sep 28, 2017

Received

Compensation History

See how much did Mark Thierer make over time.

In his interim CEO tenure for 2017, Mark Thierer received a total compensation package estimated at $5.7 million. This package was heavily influenced by a one-time signing bonus of $2.5 million, demonstrating an initial investment in his leadership. His base salary was $780,822, but no bonuses were awarded that year due to company performance metrics not being met. Thierer had also been granted stock awards with significant value, which further contributed to his total compensation. His compensation structure exemplifies a connection between executive pay and company performance, highlighting how crucial role expectations are in driving growth and accountability in leadership roles.

Year

2018

Total Compensation

$3.13M

Salary

$345.21K

Board Justification

The compensation philosophy aims to align executive compensation with corporate performance and stockholder interests, focusing on attracting and retaining key executives while balancing risk and reward.

Bonus

$0.00

Board Justification

No bonus was awarded in 2018 due to company performance.

Other

$369.23K

Board Justification

Other compensation includes severance payments received upon termination.

Restricted Stock

$2.42M(42.33K RSU)

Board Justification

The stock awards that vested in 2018 were based on prior grants, specifically 42,326 shares that vested during the year.

Performance Metrics

Performance metrics for 2018 included internal sales growth and adjusted income versus budget.